Bifemelane

From Self-sufficiency
Jump to: navigation, search
Bifemelane
File:Bifemelane.svg
Systematic (IUPAC) name
N-methyl-4-[2-(phenylmethyl)phenoxy]butan-1-amine
Identifiers
CAS Number 90293-01-9
ATC code N06AX08 (WHO)
PubChem CID 2377
Chemical data
Formula C18H23NO
Molar mass 269.381 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Bifemelane (Alnert, Celeport) is a pharmaceutical drug used in the treatment of senile dementia in Japan.[1] It has nootropic, neuroprotective, and antidepressant effects, and acts through the cholinergic system in the brain.[2][3][4] Bifemelane is also useful for the treatment of glaucoma.[5]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



pt:Bifemelano
  1. David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. p. 265. ISBN 0-412-46630-9.  More than one of |pages= and |page= specified (help)
  2. Kondo Y, Ogawa N, Asanuma M, Matsuura K, Nishibayashi K, Iwata E. Preventive effects of bifemelane hydrochloride on decreased levels of muscarinic acetylcholine receptor and its mRNA in a rat model of chronic cerebral hypoperfusion. Neuroscience Research. 1996 Mar;24(4):409-14. PMID 8861111
  3. Egashira T, Takayama F, Yamanaka Y. Effects of bifemelane on muscarinic receptors and choline acetyltransferase in the brains of aged rats following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries. Japanese Journal of Pharmacology. 1996 Sep;72(1):57-65. PMID 8902600
  4. Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
  5. Shigemitsu T, Majima Y. Use of bifemelane hydrochloride in improving and maintaining the visual field of patients with glaucoma. Clinical Therapeutics. 1996 Jan-Feb;18(1):106-13. PMID 8851457